NCBI PubMed Central
open access
Case Report: Intranasal esketamine and accelerated intermittent theta-burst stimulation for severe treatment-resistant depression with suicidal ideation.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Treatment-resistant depression and intranasal esketamine: Spanish consensus on theoretical aspects#257428
- Clinical guidance on the use of esketamine nasal spray for patients with treatment resistant depression: A European Delphi consensus report#481883
- Distinct therapeutic profiles of ketamine in treatment-resistant depression: an exploratory analysis.#218818
- A Study to Evaluate the Safety and Efficacy of Intranasal Esketamine in Treatment-resistant Depression#844985
- Using a Low Dose of Ketamine vs. Active Placebo in Treating Severe Depression and Suicide#897392
Record · ID 378430
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive